Sensyne Health: Difference between revisions
Added business details: founded 2014, funding £60M+ |
Added cross-references: AIDAVA Competitive Analysis |
||
| Line 27: | Line 27: | ||
== See Also == | == See Also == | ||
* [[AIDAVA Competitive Analysis]] | |||
* [[AIDAVA]] | * [[AIDAVA]] | ||
* [[AIDAVA Related Companies]] | * [[AIDAVA Related Companies]] | ||
Latest revision as of 17:57, 14 April 2026
What They Do[edit]
Partners with NHS trusts to analyze anonymized patient data for drug discovery and clinical research. Has agreements covering 30M+ patient records. Now rebranded as Phinial.
AIDAVA Relevance[edit]
NHS data curation at scale, anonymization, research reuse
Funding[edit]
Valuation: Rebranded to Phinial £60M+
Business Details[edit]
- Founded: 2014
- Total Funding: £60M+
- Valuation: Rebranded to Phinial
- Revenue: N/A (was AIM-listed, delisted)
- Employees: ~100 (est.)
- Key Milestones: NHS partnerships covering 30M+ patient records. Rebranded to Phinial after restructuring.